View Older Stories View More Recent Stories
-
UBS Upgrades Isuzu Motors Limited (7202:JP) (ISUZY) to Buy
-
UBS Upgrades Grupo Aeroportuario Del Sureste (ASURB:MM) (ASR) to Buy
-
Jefferies Starts IREN Ltd. (IREN) at Buy
-
Knowledge Atlas Technology (2513:HK) PT Raised to HK$1,800 at JPMorgan
-
Freedom Broker Upgrades Coda Octopus Group, Inc (CODA) to Buy
-
JPMorgan Resumes Prologis Property Mexico SA de CV (FIBRAPL:MM) at Neutral
-
Goldman Sachs Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Neutral
-
Goldman Sachs Starts Impact Therapeutics (7630:HK) at Neutral
-
Applied Digital (APLD) PT Raised to $82 at Northland
-
Applied Digital (APLD) PT Raised to $82 at Northland
-
Kotak Starts Vedanta Aluminium Metal (VAML:IN) at Buy (1)
-
Ambit Capital Starts Shadowfax Technologies (SHADOWF:IN) at Buy (1)
-
Ambit Capital Starts KEC International Ltd (KECI:IN) at Sell (4)
-
Ambit Capital Starts Kalpataru Projects International (KPIL:IN) at Buy (1)
-
Nomura/Instinet Upgrades Recruit Holdings Co., Ltd (6098:JP) (RCRUY) to Buy
-
ICICI Securities Starts Fractal Analytics (FRACTAL:IN) at Buy (1)
-
Morgan Stanley Downgrades Engene Holdings Inc. (ENGN) to Underweight
-
Barclays Downgrades Hexagon AB (HEXAB:SS) (HXGBF) to Underweight
-
Barclays Starts Octave Intelligence (OCTV) at Equalweight
-
Morgan Stanley Downgrades Curbline Properties Corp (CURB) to Equalweight
-
KKR Eyes At Least $1 Billion Stake In Medicover's India Hospital Arm, Source Says - Reuters
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 18
-
Eco (Atlantic) Oil and Gas Ltd. Announces 2026 Operational and Business Update
-
HIVE Digital to acquire 32 MW data center in Boden, Sweden
-
Kroger Q1 earnings preview: analysts eye pricing strategy update amid competition
-
HIVE Digital Technologies to Acquire 32 MW Data Center in Boden, Deepening an Eight-Year Community Partnership in Northern Sweden
-
Bengal Energy Announces Fiscal 2026 Fourth Quarter Results
-
Olympians Join Hundreds of Carson Youth to Launch City's Official Countdown to LA28 and Unveil 700-Pound Olympic Countdown Clock
-
Netlist files court actions against Samsung over memory patents
-
LiberNovo Announces Early Launch of Prime Sale, Featuring Limited Omni Bundle Flash Deals Starting Today
-
Morgan Stanley turns cautious on this IT services firm as AI soaks up tech spending
-
June 29th DEA Hearing: The Marijuana Industry That Stole the Word "Medical" Is Now Choking on It
-
Tantalex Lithium Provides Update on Glencore Financing Arrangements and Announces Proposed Strategic Partial Divestiture of Sandstone Worldwide Ltd.
-
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
-
BC Gold Mining Company Sues Province for Stripping Mining Rights as part of deal with First Nation
-
Jack Costigan Launches National Short-Term Rental and Investment Real Estate Division at Compass
-
Tiny's Metalab Ventures Celebrates Early Investment in xAI, Now Part of Newly Public SpaceX (SPCX)
-
Pirate Gold Intersects 0.54% Cu Eq over 180.8m, Including 1.48% Cu Eq over 49.4m, in New Grassroots Copper-Gold Porphyry Epithermal Discovery at Moby Dick
-
TVI Announces Filing of Q1 Interim Financials and Revocation of Management Cease Trade Order
-
SK hynix ships 12-layer HBM4E memory samples to customers
-
Dixie Gold Inc. Appoints Chief Executive Officer and Director, Obtains Extension to Notice of Deficiency
-
MustGrow Increases Non-Brokered LIFE Offering to Approximately $3.7 Million
-
Indoor Air Quality Company in Muscle Shoals, Price Heating & Air Conditioning, Marks 10 Years in Business
-
Trump Says He's Just Signed Iran Deal - Bloomberg
-
Meta Head Of Product For 'ai For Work' Transformation Is Leaving Company - Reuters
-
Bernstein sees this stock benefiting most from UK grocery market recovery
-
Great Pacific Gold Announces Results of Annual General Meeting
-
Canadian Securities Exchange Reports May 2026 Performance Figures
-
Goldco Given Best Reputation in Gold IRA Company Review by Gold IRA USA
-
Cenna Biosciences Receives FDA Clearance to Begin Phase 1a/1b Clinical Trial of 8M2D, a First-in-Class Peptide Designed to Stop the Production of Amyloid in Alzheimer's Disease
